Advanced Search

Home > Journals > Acta Phlebologica > Past Issues > Acta Phlebologica 2000 September;1(1) > Acta Phlebologica 2000 September;1(1):39-42



A Journal on Phlebology

Official Journal of the Italian College of Phlebology
Indexed/Abstracted in: EMBASE, Scopus, Emerging Sources Citation Index

Frequency: 3 issues

ISSN 1593-232X

Online ISSN 1827-1766


Acta Phlebologica 2000 September;1(1):39-42


Quality of ­life assess­ment in patients ­with chronic venous insuf­fi­ciency

Andreozzi G. M. 1, Martini R. 1, Clerici G. 2, Ferrari P. 2, Iacobelli M. 2

1 Angi­ology ­Unit ­Care, Uni­ver­sity Hos­pital of ­Padua, ­Padova, ­Italy;
2 ­Crinos, Vil­la­guardia (­Como), ­Italy

BACKGROUND: ­Chronic ­Venous Insuf­fi­ciency (CVI) is a ­chronic dis­ease, ­which dis­ability has not ­been ­appointed ­clearly, and ­until ­today it ­appears ­rarely in the ­tables of Insu­rance Com­pa­nies, and ­more of ­their ­costs (­drugs, ­elastic ­stockings) ­have not cov­ered by ­Public ­Health Ser­vice. The aim of ­this ­study has ­been to ­assess the ­impact of CVI on ­quality of ­life (QoL).
­METHODS: The ­Italian ver­sion of SF 36 ques­tion­naire, a ­self-­reported ­generic QoL-assess­ment instru­ment, has ­been admin­is­tered to 72 ­patients (29 ­males and 43 ­females) ­with CVI. ­Patients com­pleted ­alone the ques­tion­naire, ­helped by ­nurses ­only if ­required.
­RESULTS: The ­results ­have ­been com­pared ­with the ­same ­year Old ­Italian ­normal ­group (­from the val­i­da­tion ­study of SF-36 ­Italian ver­sion (­IQOLA Pro­ject). The ­patients C(0) - C(2) did not ­show any dif­fer­ence ­with the ­normal ­Italian pop­u­la­tion, inde­pen­dently ­from the eti­ology, ­anatomy or pathoph­y­sio­logy - EP - AS - PR or ES - AD - PR. In The ­group C(3-4-5-6) the QoL pro­file was sig­nif­i­cantly (p<0.01) ­worsen in Phys­ical domin­ions, inde­pen­dently ­from eti­ology, ­anatomy or pathoph­y­sio­logy ES - AD-P - PR) or ES - AD - PO+R. In ­Mental domin­ions ­only ­Role-Emo­tional has ­been ­involved.
CONCLUSION: SF-36 is a reli­able instru­ment to ­assess QoL in CVI. The ­impact of the ­advanced ­stages of CVI is ­very sig­nif­i­cant, sug­gesting ­that the ­Public ­Health Ser­vice ­should sup­port the ­cost of its treat­ment. The assess­ment of QoL, in the ­early ­stages of CVI, ­needs ­more spe­cific instru­ment.

language: English


top of page